News
The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) ...
MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery for valve disease.
MemorialCare Heart & Vascular Institute (MHVI) at Saddleback Medical Center is proud to announce today the addition of two ...
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results